Pfizer COVID-19 Vaccine Preferred By More Americans; Those Unsure Of Vaccines Prefer J&J

By on
More than 459 million vaccine doses have now been administered globally, mainly in wealthier countries.
More than 459 million vaccine doses have now been administered globally, mainly in wealthier countries. AFP / GABRIEL BOUYS

Pfizer's COVID-19 vaccine is the preferred brand of Americans who have not received their jabs but are eager to get inoculated, a recent poll shows. 

Many unvaccinated Americans remain hesitant to receive their jabs. A  new survey  from Survey Monkey shows that 51% of those who have yet to be inoculated say they will get the vaccine, with 71% of Democrats sharing this view to Republicans' 38%. 

Some 22% will not get the vaccine, with Republicans leading the pack at 33% versus Democrats at 9%. 

Twenty-seven percent (27%) also say they're still unsure -- 29% of Republicans to the Democrats' 20%. 

Of those eager to get the jab, 70% prefer the Pfizer COVID-19 vaccine, 67% prefer Johnson & Johnson's COVID-19 vaccine, and 66% are willing to get Moderna's. 

Interestingly, those still unsure of inoculations prefer J&J's vaccine (34%), followed by Pfizer (24%) and Moderna (22%).

The data comes as efforts to amp up vaccinations continue across states. According to  data  from the Centers for Disease Control and Prevention (CDC), as of March 24, 9:00 am ET, 130 million doses of COVID-19 vaccines have been administered in the U.S. A little over 25% of the population have received at least one dose, while 14% or 42.3 million have been fully vaccinated. 

Over 70% of 65-year-olds and above have received a single jab, while 43.8% are fully vaccinated. 

Data from Survey Monkey shows 47% have received the Pfizer vaccine, 46% got Moderna, and 4% have received the J&J vaccine, the latest one to get emergency use authorization. 

Join the Discussion